Pubdate: Wed, 12 Feb 2003 Source: Reuters (Wire) Copyright: 2003 Reuters Limited Author: Laura MacInnis U.S. TO EXTEND DRUG TREATMENT, TARGET TRAFFICKERS WASHINGTON, Feb 12 (Reuters) - The United States unveiled plans on Wednesday to extend its "war on drugs" through education campaigns, improved treatment access and disruptions of overseas drug markets. The Office for National Drug Control Policy, bolstered by new funding, including an extra $600 million for addiction treatment vouchers, said in its 2003 strategy report that youth drug use had begun to decline for the first time in 10 years. John Walters, director of the Office of National Drug Control Policy, said the funds would help his office meet the White House goal of reducing drug use by 10 percent over two years and 25 percent over five years. Walter's organization estimated 16 million Americans used illegal drugs and about 6 million needed addiction treatment. Adding to existing initiatives like advertising campaigns and research programs, Walters said his office worked with foreign authorities to disrupt drug trafficking in countries like Colombia, Mexico and Canada. The White House has allocated $2.1 billion for drug interdiction in its 2004 budget -- 7.3 percent more than in 2003 -- targeting marijuana, cocaine, heroin, methamphetamine and Ecstasy. It also requested $731 million in funding for the Andean Counterdrug Initiative, which targets Bolivia, Brazil, Colombia, Ecuador, Panama, Peru and Venezuela. Walters said the funding and increased cooperation with foreign authorities would help make the drug trade more dangerous and less profitable for smugglers, reducing the quantity of drugs that reach the United States. "Drug users respond to market forces because the drug trade is a market. We must make drugs scarce, expensive, and of unreliable quality," he said. Critics of U.S. drug policies denounced Walters' report, saying it masked problems with prison and law enforcement costs. "The drug war has always been a money pit, but this is funny math at its worst," said Ethan Nadelmann, executive director of the Drug Policy Alliance. - --- MAP posted-by: Josh